SciELO - Scientific Electronic Library Online

 
vol.30 issue1Severe infant botulism due to type A toxin and use of equine AB antitoxin AB after 5 days of evolution, a case report and literature reviewRelationship between the toxicity of raw Annona muricata leaves extract and 7,12-dimethylbenzathracene (DMBA) with histopathological changes in wistar rats. author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

Share


Acta toxicológica argentina

On-line version ISSN 1851-3743

Acta toxicol. argent. vol.30 no.1 Ciudad Autónoma de Buenos Aires Apr. 2022

 

ARTÍCULO ORIGINAL

Oxidative stress and changes in hematological and biochemical biomarkers in Crotalus durissus terrificus (South American rattlesnake) venom-induced acute kidney injury in rats

Estrés oxidativo y alteraciones en biomarcadores hematológicos y bioquímicos en lesión renal aguda inducida por el veneno de Crotalus durissus terrificus (cascabel de America del Sur) en ratones

Edson Hideaki Yoshida1 

Murilo Melo Juste Dini1 

Isadora Caruso Fontana Oliveira1 

José Antonio Matiello Filho1 

José Carlos Cogo1 

Maria Aliceda Cruz Hofling1 

Denise Grotto1 

Stephen Hyslop1 

Valquíria Miwa Hanai Yoshida1 

Franco Yoko Oshima1 

1Post-Graduate Program in Pharmaceutical Sciences, University of Sorocaba (UNISO), Sorocaba, SP, Brazil. 2Bioengineering Program, Technological and Scientific Institute, Brazil University. 3Post-Graduate Program in Technological and Environmental Processes, University of Sorocaba (UNISO), Sorocaba, SP, Brazil. 4Department of Biochemistry and Tissue Biology, Institute of Biology, State University of Campinas (UNICAMP), Campinas, SP, Brazil. 5Section of Pharmacology, Department of Translational Medicine, Faculty of Medical Sciences, State University of Campinas (UNICAMP), Campinas, SP, Brazil. *yoko.franco@prof.uniso.br

Abstract

Acute kidney injury (AKI) is the major cause of mortality following bites by the South American rattlesnake Crotalus durissus terrificus. We investigated the early onset of Crotalus durissus terrificus venom-induced AKI in rats within 2 h of venom injection and its attenuation by antivenom. Several biomarkers were used to monitor AKI in the absence or presence of antivenom. Male Wistar rats were divided into five groups (n=5 each): G1, rats injected with saline (control); G2, rats injected with venom (6 mg kg-1, intraperitoneally) and euthanized after 2 h to evaluate AKI; G3 and G4, rats injected with 0.9% sterile saline or antivenom 2 h after venom, respectively, and monitored until death or up to 24 h post-venom, and G5, rats injected with antivenom alone and monitored for 24 h. Blood, urine and renal tissue samples were collected immediately after death to assess oxidative stress, hematological and biochemical alterations, and renal histological damage. Venom caused AKI within 2 h (G2) that persisted for up to 8.2 ± 1.6 h (G3), as confirmed by increases in blood urea, creatinine, and renal proteinuria; these increases were attenuated by antivenom. There were no changes in blood protein concentrations in G2 and G3, whereas there were increases in blood reduced glutathione, glutathione peroxidase, and plasma TBARS (but not in catalase) that were attenuated to varying extents by antivenom. There were no marked changes in platelets or leukocytes, but an increase in erythrocytes after 8.2 h with venom alone was attenuated by antivenom. Renal glomerular and tubular damage was greatest after 2 h post-venom groups alone was attenuated by antivenom. Renal glomerular and tubular damage was greatest after 2 h post-venom and declined thereafter. Venom caused early-onset AKI, with variable effects on lipid peroxidation and oxidative stress. Antivenom attenuated the AKI, as shown by the decrease in blood urea and the normalization of proteinuria, without protecting against lipid peroxidation.

Keywords: Acute kidney injury; Antivenom; Biomarkers; Crotalus durissus terrificus; Oxidative stress

Resumen

La injuria o lesión renal aguda (LRA) es la mayor causa de mortalidad debido a las mordeduras por cascabeles Crotalus durissus terrificus. Se estudió la instalación precoz de LRA, en ratas, inducida por el veneno de Crotalus durissus terrificus después de 2 h de su inoculación y la atenuación por el antiveneno. Se utilizaron diversos biomarcadores para monitorear LRA en ausencia o presencia del antiveneno. Ratas Wistar machos fueron divididos en 5 grupos (n=5 por grupo): G1, ratas inoculadas con solución salina (control); G2, ratas inoculadas con veneno (6 mg kg-1 dosis, vía intraperitoneal), y sacrificadas después de 2 h para evaluar LRA; G3 y G4, ratas inoculadas con 0.9% de solución salina esterilizada o antiveneno luego de 2 h después de inoculado el veneno, respectivamente, y monitoreadas hasta su muerte o hasta 24 h después de inoculado el veneno; y G5, ratas inoculadas con antiveneno solo y monitoreadas durante 24 h. Las muestras de sangre, orina, y tejido renal fueron colectadas inmediatamente después de la muerte de los animales para evaluar estrés oxidativo, alteraciones hematológicas y bioquímicas, y daño histológico renal. El veneno causó LRA dentro de las 2 h (G2) persistiendo durante más de 8,2 ± 1,6 h (G3), estando esto confirmado por el incremento de urea sanguínea, creatinina, y proteinuria renal; estos aumentos disminuyeron con la aplicación del antiveneno. No se observaron alteraciones en las concentraciones de proteínas sanguíneas en G2 y G3, mientras que se encontraron incrementos en glutatión reducido sanguíneo, glutatión peroxidasa y TBARS plasmática (pero no en catalasa), que disminuyeron con la aplicación del antiveneno aunque en diferente grado. No ocurrieron alteraciones marcadas de plaquetas o leucocitos, mientras que el aumento de glóbulos rojos observado luego de 8,2 h de la inoculación con veneno, disminuyó con el antiveneno. El daño renal glomerular y tubular fue más importante luego de 2 h de la inoculación con veneno y posteriormente disminuyó. El veneno causó LRA precoz a las 2 h, con efectos variables sobre la peroxidación lipídica y el estrés oxidativo. El antiveneno redujo el daño renal, conforme lo demostrado por la disminución en la urea sanguínea y por la normalización de la proteinuria, aunque no se observó protección contra la peroxidación lipídica.

Palabras clave: Antiveneno; Biomarcadores; Crotalus durissus terrificus; Estrés oxidativo; Lesión renal aguda

Background

Nephrotoxicity is an important clinical com-plication of snakebite by crotalid and viperid snakes (Warrell 2004; Sitprija 2006; Albuquer-que et al. 2013, Gutiérrez et al. 2017; Albuquer-que et al. 2020) and is frequently characterized by a combination of acute tubular necrosis, acute tubulointerstitial nephritis, renal cortical necrosis, mesangiolysis, vasculitis, glomerulo-nephritis, proteinuria, hematuria, and myoglo-binuria (Sitprija 2006, 2008), as well as altera-tions in renal ion transport (Sitprija and Sitprija, 2016). The high vascularization of the kidneys and their involvement in blood filtration and the excretion of endogenous and xenobiotic substancies makes these organs particularly prone to the actions of circulating snake venoms and their toxins (Sitprija 2006, 2008; Sanhajariya et al. 2018).

In Brazil, most cases of snakebite-induced acute kidney injury (AKI) result from envenom-ation by lanceheads (Bothrops spp.) and the South American rattlesnake (Crotalus durissus terrificus = C. d. terrificus) (Pinho et al. 2008; Rodrigues Sgrignolli et al. 2011; Berger et al. 2012; Albuquerque et al. 2013). Although Bothrops spp. are responsible for 87% of the bites by venomous snakes in this country compared to 9% by C. d. terrificus (data for the period 2001-2014), the overall mortality associated with the latter species is 2.6-fold greater than with the former genus (0.97% vs. 0.37%) (SIN-AN 2019). The greater lethality associated with envenomation by C. d. terrificus has been at-tributed primarily to its high content of crotox-in, a phospholipase A (PLA2) p-neurotoxin that accounts for ~50% of the venom dry weight (Hadler and Vital Brazil 1966; Sampaio et al. 2010).

Snake venom PLA display a variety of activi-ties, such as presynaptic neurotoxicity, myone-crosis, edema formation, cardiotoxicity, antico-agulant activity, activation/inhibition of platelet aggregation, hemorrhage, hemolysis and cy-totoxicity (Kini 2003; Harris and Scott-Davery 2013). Most of these effects reflect the PLA2-mediated hydrolysis of cell membrane phos-pholipids to release arachidonic acid that can be oxidized to generate reactive oxygen species (ROS) that in turn produce lipid peroxides, leading to cellular injury (Spiteller et al. 2001; Kini 2003; Teixeira et al. 2003).

Human envenomation by C. d. terrificus is characterized by peripheral neurotoxicity (palpebral ptosis, external ophthalmoplegia and facial weakness that produce ‘myasthenic facies’, generalized muscle weakness, mydriasis and, rarely, respiratory failure requiring mechanical ventilation), systemic myonecrosis (rhabdomy-olysis, with a marked increase in serum myo-globin and creatine kinase, and myoglobinuria, as well as generalized myalgia), coagulopathy (afibrinogenemia leading to prolonged clotting time with no thrombocytopenia), and AKI, with little or no local manifestations such as hemorrhage, edema or necrosis at the bite site (pain related to traumatism caused by the bite may be present but is soon followed by paresthe-sia and anesthesia) (Amorim and Mello 1954; Rosenfeld 1971; Azevedo-Marques et al. 1985, 1987; Silveira and Nishioka 1992; Sano-Mar-tins et al. 2001; Bucaretchi et al. 2002; Warrell 2004; Pinho et al. 2005; Berger et al. 2012; Fra-re et al. 2019; Medeiros et al. 2020). AKI is the major clinical complication and the principal cause of death in individuals who survive the severe initial phase of envenomation (Pinho et al. 2005; Frare et al. 2019).

Although the clinical profile of AKI induced by C. d. terrificus venom in humans has been ex-tensively studied, with an important mechanism of kidney damage being the renal deposition of myoglobin released by the rhabdomyolytic ac-tivity of the venom (Rosenfeld 1971; Azevedo-Marques et al. 1985, 1987; Silveira and Nish-ioka 1992; Bucaretchi et al. 2002; Warrell 2004; Pinho et al. 2005; Albuquerque et al. 2013; Fra-re et al. 2019), relatively few experimental stud-ies have investigated the mechanisms involved in this phenomenon. The renal lesions caused by this venom in humans can be reproduced to varying extents in dogs (Sangiorgio et al. 2008) and mice (Frezzatti and Silveira 2011). In mice, C. d. terrificus venom causes renal dysfunction and oxidative stress (Yamasaki et al. 2008) that can be attenuated to varying extents by com-pounds such as lipoic acid (Alegre et al. 2010), allopurinol (Frezzatti and Silveira 2011), and N-acetyl-L-cysteine (Barone et al. 2014). The renal functional alterations seen after enven-omation may be mediated directly by venom components such as crotoxin/PLA (Monteiro et al. 2001; Amora et al. 2008) or indirectly by mediators released by cells such as macro-phages exposed to the venom (Martins et al. 2003; Cruz et al. 2005).

Physiological and pathophysiological studies have shown that rats respond more like hu-mans than do mice and has led to the extensive use of these rodents as a model for investigat-ing normal and diseased states (National Human Genome Research Institute 2004), but no reports have examined the response to C. d. terrificus venom in this species. Hence, in this work, we examined the ability of C. d. terrificus venom to induce AKI after intraperitoneal (i.p.) injection in rats as a potentially useful model for the experimental evaluation of new therapeutic strategies to treat systemic envenomation.

We assessed AKI 2 h after venom injection to simulate the time interval between envenom-ation and seeking medical assistance in the clinical setting, including antivenom administraron [mean interval of 3 h, according to Pinho et al. (2005)]. The occurrence of AKI was consid-ered a positive confirmation of envenomation, and several other biochemical, hematological, and histological parameters were monitored to assess the extent of renal damage. We also examined the ability of antivenom given i.p. 2 h post-venom to rescue rats from the lethal ef-fects of the venom and to attenuate the renal functional alterations associated with AKI.

Methods

Animals

Standard laboratory practices for animal care were followed according to the Guide for the Care and Use of Laboratory Animals (National Research Council of the National Academies 2011) and the Animal Research: Reporting of In vivo Experiments (ARRIVE) guidelines (Kilkenny et al. 2010). The experimental protocols were approved by the institutional Committee for the Care and Use of Experimental Animals at the University of Sorocaba (protocol no. 031/2014). Male Wistar rats (Rattus norvegicus) (290-400 g; 3-6 months old) purchased from the Central Animal Facility of the Institute of Biomedical Sciences of the University of Sao Paulo (Sao Paulo, SP, Brazil) were housed (3 rats/plas-tic cage on a wood shavings substrate) at the University of Sorocaba animal facility at 22 ± 3 oC and 50 ± 5% humidity on a 12 h light/dark cycle (lights on at 6 a.m.), with access to food and water ad libitum.

Venom

Crotalus d. terrificus venom was collected manually from 20 male and female young adult snakes (200-400 g, ~2 years-old) captured in the Paraiba Valley close to the city of Sao José dos Campos (23° 11’ 0” S; 45° 53’ 0” W) and kept in the serpentarium of the Center for Na-ture Studies (under Environmental Secretariat License SMA 15.380/2012) at the University of Vale do Paraiba (UNIVAP, Sao José dos Campos, SP, Brazil). The use of the venom was reg-istered with the Brazilian National System for the Management of Genetic Patrimony and Associated Traditional Knowledge (SISGEN, registration no. ACB5FCO). The venom was ly-ophilized and stored at 4-8 °C until used.

Antivenom

Therapeutic crotalic antivenom raised against C. d. terrificus venom (lot 135202/I, expiry date for human use: October 2016) produced by the Instituto Vital Brazil (Rio de Janeiro, RJ, Brazil) was kindly donated by the Escritorio Regional de Saúde (ERSA) in Piracicaba, SP, Brazil. Al-though the antivenom was used beyond the expiry date for human use, the solution nev-ertheless conserved the macroscopic proper-ties generally considered to be indicative of quality maintenance, i.e., lack of turbidity and no formation of precipitates. Indeed, previous studies have demonstrated the usefulness of antivenoms beyond their formal expiry dates (O'Leary et al. 2009; Sánchez et al. 2019; Tan et al. 2019). The dose of antivenom was calcu-lated based on the manufactureras stated po-tency in which 1 mL of antivenom neutralizes the lethality of 1.5 mg of reference C. durissus ssp. venom in mice.

In vivo protocols

All rats were anesthetized i.p. (always on the left side) using a schedule based on the Guide for the Care and Use of Laboratory Animals. The anesthetic mixture consisted of xylazine (10 mg kg-1) and ketamine (10 mg kg-1) (both purchased from Ceva®, Paulínia, SP, Brazil), with midazolam (1 mg kg-1) being used for ini-tial sedation (before venom administration) and tramadol (5 mg kg-1) as an analgesic (both from Medley®, Campinas, SP, Brazil) administered soon after venom injection.

Urine, blood, and renal tissue samples were collected at death (with venom alone, ~8.2 h post-venom; see later) or 2 h or 24 h post-ven-om when the rats were killed with an overdose of isoflurane (Cristália®, Itapira, SP, Brazil). He-matological (leukocytes, platelets, and erythro-cytes) and biochemical (protein, creatinine, and urea) parameters were determined in blood and urine, whereas blood and renal tissue samples were used to evaluate oxidative stress markers (glutathione - GSH, glutathione peroxidase -GPx, catalase - CAT, thiobarbituric acid reactive substances - TBARS). Alterations in renal morphology were analyzed by light microscopy. In a preliminary set of experiments, rats were injected with different doses of C. d. terrificus venom (5, 6, 7.5, and 10 mg kg-1, i.p.; one dose per rat, n=3 rats/dose, a total of 12 animals) to determine an appropriate minimal venom dose able to induce AKI. The venom was injected in a volume of 0.5 mL, which is considerably less than the volume of 10 mL kg-1 recommended elsewhere (Morton et al. 2001), and the venom dose of 6 mg kg-1 was selected based on a marked increase in blood urea and creatinine concentrations. These biomarkers are fre-quently used as indicators of renal dysfunction because they reflect a decrease in the glomeru-lar filtration rate in response to renal alterations (Sato 2012). The rats were randomly distrib-uted into five groups (n=5/group; total N = 25 rats), as follows: Group 1 (G1) - Saline (sham) control (n=5): Rats received 0.5 mL of sterile phosphate-buffered saline (PBS, i.p.) and were killed 2 h later with an overdose of isoflurane for blood and tissue sample collection; Group 2 (G2; n=5) - rats were injected with C. d. terrificus venom (6 mg kg-1, i.p.) and killed 2 h later with an overdose of isoflurane for blood and tissue sample collection. Pharmacokineti-cally, this 2 h interval provided sufficient time for the absorption and diffusion of the venom and its main toxin, crotoxin, from the site of ap-plication (Barral-Netto and von Sohsten 1991; Cura et al. 2002), with subsequent binding to the presynaptic terminations of striated muscle (Cura et al. 2002); Group 3 (G3) - Assessment of survival time (n=5): Rats were injected with venom (6 mg kg-1, i.p.) and 2 h later received PBS (0.5 mL, i.p., n=5) after which they were monitored until imminent death when blood and tissue samples were collected; the rats in this group survived for 8.2 ± 1.6 h. Group 4 (G4) - C. d. terrificus venom followed by antivenom (n=5): Rats were injected with venom (6 mg kg-1, i.p.) and 2 h later they received crotalic antivenom (from 1.3 to 1.9 mL, i.p.; 1 mL of antivenom neutralizes 1.5 mg of C. d. terrificus reference venom, according to the manufacturer) in a rescue model conceptualized by Baudou et al. (2017); blood and tissue samples were collected 24 h after venom injection (22 h af-ter antivenom). Group 5 (G5) - PBS followed by antivenom (n=5): Rats were injected with PBS (0.5 mL, i.p.) and 2 h later they received crotalic antivenom i.p. (the same volume as in group G4); blood and tissue samples were collected 24 h after PBS injection (22 h after antivenom). The rats in groups G4 and G5 were killed with an overdose of isoflurane before blood and tis-sue sample collection.

Groups G1-G5 were all injected with PBS, venom, or antivenom on the right side. Figure 1 shows the experimental schedule described above.

Hematological parameters Blood samples were collected in polypropyl-ene tubes (Injex® Indústria Cirúrgica Ltda., Ourinhos, SP, Brazil) containing ethylenediami-netetraacetic acid tripotassium salt (EDTA). Total leukocyte, platelet and erythrocyte counts were determined in triplicate per sample using a Sysmex XS 1000i™ Hematology Analyzer (Roche, Basel, Switzerland). Whole blood samples (~20 pL) were injected into the analyzer and platelets and erythrocytes were counted using an impedance detection method com-bined with hydrodynamic focusing technology (Yoshida et al. 2020). Leukocytes were counted using fluorescent flow cytometry.

Assessment of oxidative stress Glutathione (GSH) was determined by sulfhy-dryl (SH) quantification using the Ellman meth-od (Ellman 1959). Briefly, 100 pL of Triton X-100 was added to 150 pL of blood followed by 100 pL of 10% trichloroacetic acid (TCA). After centrifugaron (5,000 rpm, 10 min, 4 oC) the super-natant was diluted in 1 M phosphate buffer (pH 7.4) and an aliquot was subsequently mixed with 10 mM 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB) to yield a yellow complex, the absor-bance of which was read at 412 nm. A similar procedure was used for renal tissue homoge-nates in which 250 mg of tissue was suspended in 5 mL of 0.15 mM KCl and homogenized with an ultrasonic tissue homogenizer in an ice bath. Thereafter, 600 pL of homogenate was mixed with 100 pL of TCA, centrifuged, and an aliquot of 250 pL was diluted in PBS and mixed with 10 mM DTNB. The GSH concentraron was expressed in mM for blood or mmol g-1 for tissue.

Glutathione peroxidase (GPx) activity was as-sayed according to Paglia and Valentine (1967). Briefly, 10 pL of diluted blood was mixed with 390 pL of 100 mM potassium phosphate buffer, pH 7, containing 1 mM GSH, 0.1 U of GSH-reductase/mL, 0.15 mM nicotinamide adenine dinucleotide phosphate (NADPH), 1.25 mM so-dium azide and 100 pL of 0.4 mM hydrogen per-oxide (H2O2). Tissue samples were processed as described in the preceding paragraph. GPx activity was monitored as the decay in NADPH absorbance (greater activity = greater decay) for 2 min at 340 nm and was expressed in pmol NADPH min-1 g-1 of hemoglobin (Hb) for blood, or nmol NADPH min-1 g-1 of tissue.

Catalase (CAT) activity was assayed according to Aebi (1984). Briefly, 10 pL of blood was diluted in 590 pL of 50 mM potassium phosphate buffer, pH 7. A 20 pL aliquot was mixed with 70 pL of H2O2 to start the reaction and the enzymatic decomposition of H2O2 by CAT was monitored for 3 min at 240 nm. The reaction was run at 25 °C. A similar procedure was used for tissue homogenates prepared as described above. Enzyme activity was expressed as k min-1 g-1 of Hb for blood or k min-1 g-1 of tissue, where k is a rate constant.

Lipid peroxidation was assessed by quantifying thiobarbituric acid reactive substances (TBARS) according to Ohkawa et al. (1979). Briefly, 150 pL of plasma was mixed with 50 pL of 3 M NaOH and incubated at 60 oC for 30 min. This step was followed by the addition of 250 pL of 6% H3PO4, 250 pL of 0.8% thiobarbituric acid (TBA), and 100 pL of 10% sodium dodecyl sulfate (SDS) followed by incubation at 80 oC for 60 min. A similar procedure was used for tissue homogenates prepared as described above. Thereafter, 250 pL of the homogenate was mixed with 1.5 mL of 6% H3PO4, 500 pL of 0.8% TBA and 100 pL of 10% SDS. The reaction between lipid peroxidation products and TBA results in a pink/rose-colored compound detected spectro-photometrically at 532 nm. The results were expressed as TBARS concentration in pmol mL-1 of plasma or pmol g-1 of tissue.

Biochemical parameters The biochemical parameters of renal function were assessed using commercial ready-to-use kits for spectrophotometric assays purchased from Bioclin® (Belo Horizonte, MG, Brazil) or Labtest® (Lagoa Santa, MG, Brazil). Total pro-tein (biuret method; 545 nm), urea (urease method; 600 nm) and creatinine (alkaline pic-rate method; 510 nm) were evaluated in blood samples; urinary protein was quantified by the pyrogallol red method (600 nm), while urinary urea and creatinine were assayed with the same kits as used for blood samples. Control serum (Biocontrol N, normal) was used as an internal control and yielded the following val-ues: protein = 5.3 g dL-1 (normal range values (NRV) provided by the manufacturer: 4.7-5.9 g dL-1), urea = 16.0 mg dL-1 (NRV: 12.0-20.0 mg dL-1) and creatinine =1.43 mg dL-1 (NRV: 1.141.72 mg dL-1).

Histological analysis of renal tissue At the end of the experiments, the kidneys from groups G1-G5 (n=5/group) were excised, washed in physiological solution, and imme-diately fixed in 10% buffered formalin solu-tion for 24 h at room temperature. The kidneys were then sectioned sagittally and immersed in 70% ethanol until histological processing us-ing standard procedures for dehydration and embedding in paraffin. Sections (4 pm thick) were mounted on slides, dewaxed, cleared in xylene, and hydrated in running tap water, af-ter which they were double-stained with hema-toxylin-eosin (H&E) and examined with a light microscope (Olympus CBA, Tokyo, Japan). The slides from each group were examined for venom-induced alterations to the following structures: the glomeruli (hypercellularity due to mesangial proliferation and/or invasion, di-lation of glomerular capillaries to form micro-aneurysms), tubules (loss of brush border, oc-currence of cell swelling, hydropic alterations, presence of luminal cell casts), interstitium (medullary or cortical proliferation and/or loss of interstitium) and vessels (congestion, partic-ularly in the arterioles). The potential protective effects of crotalic antivenom on renal morphol-ogy were also assessed. Representative histological fields from each group were captured using a digital 16-megapixel camera, with a 10x objective for a panoramic overview (1 cm = 20 pm) and a 40X objective (1 cm = 40 pm) for a detailed view.

Figure 1: Experimental timeline for induction of AKI with C. d. terrificus venom (6 mg kg-1, i.p.) and subsequent treatments. AKI, acute kidney injury; Antivenom, crotalic antivenom; PBS, phosphate-buffered saline. 

The observational frequency of such alterations ranged arbitrarily from 0 to 6, with 0-1 representing the absence or presence of few alterations (the latter mainly due to tissue ma-nipulation), 2-3 indicating a moderate number of alterations, and 5-6 representing a high frequency of morphological alterations.

Data analysis

All numerical parameters were expressed as the mean ± SD. Statistical comparisons among the experimental groups were done using one-way ANOVA followed by the Tukey-Kramer multiple comparisons test, with p<0.05 indicating sig-nificance in all cases. The normality of the data was assessed using the Shapiro-Wilk test prior to the statistical comparisons. All data analy-ses were done using Origin© v.8.0 (OriginLab Corporation, Northampton, MA, USA) or Sta-tistica v.8.0 (Dell, Round Rock, TX, USA).

Results and discussion

Crotalus d. terrificus venom induces AKI in hu-mans (Warrell 2004; Pinho et al. 2005, 2008; Albuquerque et al. 2013) and experimental animals such as mice (Yamasaki et al. 2008); venom-induced renal lesions have also been reported in dogs (Frezzatti and Silveira 2011), although this species is resistant to AKI (Sousa-e-Silva et al. 2003). Whereas the venom of C. d. terrificus and related subspecies causes func-tional and histological alterations in rat isolated perfused kidneys (Monteiro et al. 2001; Amora et al. 2008), the renal effects of C. d. terrificus venom in vivo in rats have not been investigat-ed, in contrast to Bothrops venoms (Boer-Lima et al. 1999, 2002; Linardi et al. 2011; Gois et al. 2017; Yoshida et al. 2020). In this work, we examined the ability of C. d. terrificus venom injected i.p. to induce AKI in rats and the ability of antivenom to protect against this dam-age. We also assessed the potential changes in several renal biochemical, hematological, and histological parameters in response to the venom. Although not the normal or usual route of venom inoculation during a ‘natural’ bite, at least in humans, i.p. injection of venom could potentially occur in rodent prey bitten by snakes with long fangs. Since there have been no experimental studies of AKI induced by C. d. terrificus venom in rats we chose to use this route of administration because we had used it in an earlier investigation of AKI caused by Bothrops jararaca venom (Yoshida et al. 2020). The results of this study show that venom injected i.p. was able to cause AKI and that this could be a suitable model for studying venom-induced renal damage.

Biochemical parameters Rats injected with venom (groups G2 and G3, but especially G3) showed an increase in the blood (Fig. 2A,C) and urine (Fig. 2B,D) con-centrations of urea and creatinine compared to rats injected with saline alone (control, G1), a finding compatible with the development of AKI. The persistent elevation in blood urea and creatinine concentrations for up to 7.2 h indi-cated sustained and worsening renal damage after venom injection. Increases in urea and creatinine are standard criteria for defining and monitoring the progression of AKI (Mehta et al. 2007; Cerdá et al. 2008) but are considered by some to be insensitive, nonspecific, and of limited usefulness for the early detection of AKI (Vaidya et al. 2008). Although blood pro-tein concentrations were generally unaltered (Fig. 2E), proteinuria indicative of defective glomerular filtration was observed (Fig. 2F). Renal proteinuria is a common indicator of AKI and is frequently seen after snakebites (Sitprija 2006), including by C. d. terrificus in humans (Pinho et al. 2005), dogs (Sousa-e-Silva et al. 2003), as well as rats (as shown here; Fig. 2F).

Figure 2: Urea, creatinine, and protein concentrations in blood (A, C, and E, respectively) and urine (B, D, and F, respectively) in rats injected with phosphate-buffered saline (PBS; G1), C. d. terrificus venom (6 mg kg-1, i.p.; G2 - analyzed 2 h post-venom; G3 - analyzed 7.2 h post-venom), venom + C. d. terrificus antivenom (G4, analyzed 24 h post-venom) and antivenom alone (G5 -24 h after antivenom). In groups G4 and G5, antivenom was administered 2 h after the injection of venom (G4) or PBS (G5). The antivenom:venom ratio used was based on the manufacturer's recommended ratio in which 1 mL of antivenom neutralizes the lethality of 1.5 mg of reference C. durissus ssp. venom in mice. The columns represent the mean ± SD (n=3-5/group). p<0.05 compared to G1(*), G2(#), G3(@), and G4(&). 

Antivenom administered 2 h after venom was effective in preventing the increase in blood urea and renal proteinuria (Fig. 2A,F), but failed to prevent the changes in the other blood and urinary biochemical parameters (Fig. 2B-E). Most of these alterations are likely mediated by crotoxin that is rapidly cleared from the circu-lation in mice (Barral-Netto and von Sohsten, 1991) and Amaral et al. (1997) reported that C. d. terrificus venom and crotoxin were un-detectable in most of their patients who were treated >8 h post-bite, and that crotoxin was undetectable in most patients by 4-8 h after being bitten. A kinetic analysis has shown that in humans crotoxin has a distribution half-life of 22 min and a terminal elimination half-life of 5.2 h (Cura et al. 2002). As shown here, by 2 h post-venom, when a considerable propor-tion of the crotoxin would have been distrib-uted and bound to tissues, antivenom still of-fered some protection against the deleterious effects of the venom. The time interval of 2 h after venom injection used here was chosen to simulate the delay seen clinically between envenomation and treatment since in humans the mean interval between these events is ~3 h and antivenom is frequently given at post-envenomation intervals that are considerably greater than that used here (Bucaretchi et al. 2002; Pinho et al. 2005).

The lack of protection by antivenom against certain venom-induced alterations may reflect the availability of a less than optimal amount of antivenom to neutralize that particular effect, even though the antivenom:venom ratio used was that recommended by the manufacturer; poor neutralization because of a suboptimal amount of antivenom has also been noted by others (Baudou et al. 2017).

Crotalic antivenom did not prevent the venom-induced increase in urinary creatinine, but instead markedly enhanced the level of this marker (~10-fold increase compared to saline control in G1 and ~5-fold increase compared to G3; Fig. 2D). The marked elevation in creatinine in this group 22 h after antivenom administraron was possibly related to venom-induced muscle damage (rhabdomyolysis), with the re-sulting myoglobinuria contributing to the devel-opment of AKI (Azevedo-Marques et al. 1985, 1987; Nogueira and Sakate 2006).

Creatinine, an uncharged endogenous sub-stance (113 kDa) that is not bound to serum proteins, is generated from the nonenzymatic conversion of creatine and creatine phosphate, 95% of which is found in muscle (Thong-prayoon et al. 2016). As shown here, antivenom alone increased the creatinine concentration in blood and urine after 22 h (Fig. 2C,D), although the increase in urine was less than in G4 rats. One possible explanation for the antivenom-induced increase in serum creatinine could be related to changes in creatinine kinetics (in this case enhanced elimination) resulting from alterations to the glomerular filtration rate (GFR), as occurs in paraquat poisoning (Mohamed et al. 2015). This finding suggests that the increase in creatinine concentrations in G4 rats treated with antivenom should not be attribut-ed entirely to C. d. terrificus venom. In contrast to this effect, antivenom alone (G5) reduced the proteinuria to below the baseline concentration in G1 (Fig. 2F). This change had minimal effect on the creatinine concentration because creatinine shows little tendency to bind other proteins.

Oxidative stress parameters The antioxidant system of tissues, which con-sists of a series of enzymes and small mol-ecules, provides an effective defense mecha-nism against renal damage by xenobiotics by delaying or inhibiting the oxidation of sub-strates and the generation of damaging reactive oxygen species (ROS) (Ferreira and Mat-subara 1997). An increase in antioxidant en-zyme activity generally has a protective effect whereas a decrease can lead to renal damage. Given the physiological importance of anti-oxidant mechanisms in tissue protection and the fact that lipid peroxidation, one of the first events in oxidative damage initiated by ROS, has been implicated in snake venom toxicity (Santosh et al. 2013), we examined the chang-es in lipid peroxidation (TBARS) and oxidative stress (GSH, GPx and CAT activity) in blood and renal tissue of rats injected with C. d. ter-rificus venom and the ability of crotalic antive-nom to protect against these alterations.

Lipid peroxidation is a free radical-mediated chain of reactions that results in the oxidation of polyunsaturated lipids (Hampel et al. 2016), leading to the damage of membrane lipids and the attenuation of cell and tissue viability (Mylo-nas and Kouretas 1999). Figure 3A,B shows that 2 h post-venom (G2) there was no relevant increase in blood TBARS, whereas shortly before death (~8 h post-venom) TBARS had increased by approximately two-fold; there was no signif-icant change in the TBARS levels in urine. This finding that TBARS increased in G3 but not in G2 indicated that lipid peroxidation was a late event and agrees with previous studies show-ing that C. d. terrificus venom and some of its components cause lipid peroxidation in other tissues (Silva et al. 2011; Gongalves et al. 2014; Toyama et al. 2019). Treatment with antivenom 2 h post-venom did not attenuate the venom-induced increase in TBARS, possibly because antivenom alone also caused some lipid peroxidation.

Glutathione, which exists in reduced (GSH) or oxidized (GSSG) states, is one of the most im-portant ROS scavengers (Halliwell and Gutter-idge 1999) and increases in GSH levels have been observed in patients with chronic renal failure, possibly as a compensatory protec-tive mechanism to deal with the oxidative imbalance produced by kidney disease (Lucchi et al. 2005). As shown here, there was only a small increase in blood GSH in response to venom alone after 2 h and ~8 h (Fig. 3C,D) but a marked increase in renal GSH after 2 h (G2) that returned to normal after ~8 h (G3). Treatment with antivenom (G4) attenuated the small increase in blood GSH seen with venom alone after ~8 h but did not markedly affect the renal levels of GSH. Antivenom alone (G5) slightly reduced the concentration of circulating (blood) GSH but increased the renal content of GSH. Glutathione peroxidase (GPx) is a selenium-containing antioxidant enzyme that reduces H2O2 to water and lipid peroxides to lipid alco-hols. In the absence of adequate GPx activity or GSH levels, hydrogen and lipid peroxides are not detoxified and are converted to OH- and lipid peroxyl radicals, respectively, by transi-tion metals (Fe2+) (Tabet and Touyz 2007). GPx oxidizes glutathione to glutathione disulfide in the cytosol, mitochondria, and a small percent-age of the endoplasmic reticulum of mamma-lian tissues (Lu 2013). Glutathione is released as reduced GSH to extracellular spaces, in-cluding blood plasma, epithelial lining fluids, and exocrine secretions (Ballatori et al. 2009) in response to physiological disturbances. The GSH/GPx system thus acts as a buffer to pro-tect crucial proteins against modifications in-duced by rOs (Chen et al. 2015).

Figure 3: Oxidative stress biomarkers (TBARS, GSH, GPx, and CAT) in blood (A, C, E, and G, respectively) and urine (B, D, F and H, respectively) of rats injected with phosphate-buffered saline (PBS; G1), C. d. terrificus venom (6 mg kg-1, i.p.; G2 - analyzed 2 h post-venom, G3 - analyzed 7.2 h post-venom), venom + C. d. terrificus antivenom (G4, analyzed 24 h post-venom) and antivenom alone (G5 - 24 h after antivenom). In groups G4 and G5, antivenom was administered 2 h after the injection of venom (G4) or PBS (G5). The antivenom:venom ratio used was based on the manufacturera recommended ratio as defined in the legend of Figure 2. The columns represent the mean ± SD (n=5/group). *#p<0.05 indicate differences compared to G1(*) or G2(#). CAT, catalase; GPx, glutathione peroxidase; GSH, glutathione; TBARS, thiobarbituric acid reactive substances. 

Venom caused an increase in blood GPx activ-ity after 2 h but this returned to below saline (control) levels after ~8 h (Fig. 3E). Antivenom did not markedly alter the response to venom (G4) compared to that seen in G3, nor did antivenom alone have a relevant effect on GPx activity. There were no marked venom-induced alterations in renal GPx activity after 2 h and ~8 h with venom alone, or after treatment with antivenom (Fig. 3F).

CAT is an enzyme located in peroxisomes that converts H2O2 to water and oxygen (Weydert and Cullen 2010). Neither venom nor antivenom (in the absence or presence of venom) markedly affected the blood CAT activity (Fig. 3G), but there was a venom-induced increase in the activity of this enzyme in renal tissue after ~8 h that was not attenuated by antivenom; an-tivenom alone increased the renal CAT activity to a level like venom alone (Fig. 3H). Indeed, antivenom alone (G5) enhanced the levels of several parameters, particularly blood and uri-nary creatinine, and to a lesser extent, renal GSH, blood TBARS and renal CAT in relation to saline-treated (control) rats but reduced the level of blood GSH and renal proteinuria.

These findings suggest that antivenom alone can alter the redox status in blood and renal tissue by mechanisms that could involve the activation of defense pathways against horse immunoglobulins (Bahrami et al. 2016) and an adverse reaction to antivenom (Silva et al. 2015). Adverse reactions to snake antivenom include both acute (anaphylatic or pyrogenic) and delayed (serum sickness type) reactions (León et al. 2013; de Silva et al. 2016; Negrin et al. 2021), but no reports have described such reactions in response to the i.p. injection of antivenom in rats. Intraperitoneal injection is con-sidered a safe route of administration (Guarni-eri 2016; Al Shoyaib et al. 2019), but no studies have reported on the renal responses to cro-talic antivenom alone, such as done here. The i.p. administration of bothropic antivenom in rats resulted in proteinuria (Yoshida et al. 2020), one of the earliest signs of renal diseases and indicative of glomerular damage (Gowda et al. 2010). Thus, it is possible the potential effect of antivenom itself on a variety of parameters may have been masked by the concomitant admin-istration of venom in studies that did not include an experimental group with antivenom alone. An additional source of interference could be the phenol used as a preservative in antivenom solutions since this chemical can impair leuko-cyte-endothelial interactions in vivo (Zychar et al. 2008), and high phenol inhalation for several weeks paralysis and severe injury to the heart, liver, kidneys, and lungs, and in some cases, death in experimental animais (Agency for Tox-ic Substances and Disease Registry 2008). The use of lyophilized antivenom (Mendonga-da-Silva et al. 2017) could potentially avoid phe-nol-related problems.

Hematological parameters Hematological alterations are a common manifestaron of systemic envenoming after snake-bite and the detection of abnormal blood parameters is an important step in the manage-ment of envenomed persons. Figure 4 shows the hematological results for the various experimental groups. There was a slight reduction in leukocyte numbers in G2 and mild leukocytosis in G3; treatment with antivenom appeared to attenuate the leukocytosis in group G4. This at-tenuation may have been partly mediated by the antivenom itself, independently of its effect on venom, since antivenom alone caused a reduction in leukocyte numbers. Mild leukocytosis has been observed in humans (Sano-Mar-tins et al. 2001) and dogs (Sousa-e-Silva et al. 2003; Nogueira and Sakate 2006; Nogueira et al. 2007) envenomed by C. d. terrificus and has been attributed to neutrophilia (Sousa-e-Silva et al. 2003). Nogueira et al. (2007) argued that this neutrophilia involved an acute-phase response with the release of catecholamines and cellular mediators; serum chemotactic factors have also been implicated in human envenom-ation by C. d. terrificus (Martins et al. 2002). Souza-e-Silva et al. (2003) reported that leuko-cytosis persisted for up to 48 h in dogs injected with a venom dose of 1 mg kg-1, i.m., and was reversed by treatment with antivenom i.v. 2 h after envenomation, as also observed here in rats using antivenom (G4 in Fig. 4A).

Platelet number was unaffected by the venom (Fig. 4B), a finding in general agreement with studies in dogs (Sousa-e-Silva et al. 2003) and humans (Sano-Martins et al. 2001) that also reported unaltered platelet numbers after envenomation by C. d. terrificus. Antivenom alone (G5) did not affect platelet number but decreased this number when associated with venom (G4). However, this decrease was not clinically relevant since there was no significant difference compared to saline-treated (control) rats (G1). The lack of effect on circulating platelet numbers could perhaps be the most useful parameter for distinguishing between clinical envenomation by C. d. terrificus (Sano-Martins et al. 2001) and Bothrops species (Sano-Martins et al. 1997; Yoshida et al. 2020) since venoms of the latter genus can cause marked thrombocytopenia. Such a distinction would be of clinical relevance in facilitating the choice of the appropriate antivenom, thereby ensuring better treatment of the patient, particularly in cases where the offending snake is not brought for identification.

Figure 4: Hematological parameters (leukocyte, platelet and erythrocyte counts) in rats injected with phosphate-buffered saline (PBS; G1), C. d. terrificus venom (6 mg kg-1, i.m.; G2 - analyzed 2 h post-venom, G3 - analyzed 7.2 h post-venom), venom + C. d. terrificus antivenom (G4, analyzed 24 h post-venom) and antivenom alone (G5 - 24 h after antivenom). In groups G4 and G5, antivenom was administered 2 h after the injection of venom (G4) or PBS (G5). The antivenom:venom ratio used was based on the manufacturera recommended ratio as defined in the legend of Figure 2. The columns represent the mean ± SD (n=3-5/ group). *#’®A##p<0.05 compared to G1 (*), G2 (#), G3 f), G4 (&), and G3 and G5 (##). 

Figure 5: Histological renal tissue assessment in groups G1 (A and B), G2 (C and D), G3 (E and F), G4 (G and H), and G5 (I and J) (scale bar = 20 µm in all major panels). Insets in all groups show renal corpuscles (scale bar = 40 µm in all inserts). G1 (control rats injected with phosphate-buffered saline; arrows indicate the normal appearance of renal corpuscles). The effects of severe damage induced by C. d. terrificus venom are seen in G2 (venom group): panel C, long arrows = widened filtration space and hypercellularity; short arrows = microaneurysms; panel D = luminal cellular casts resulting from detachment of tubular epithelial lining; G3 (rats treated with venom and saline): panel E = hyalinization of both cortical segments and glomeruli; panel F, medullary segments showing few alterations. G4 (rats treated with venom and antivenom) and G5 (rats treated with antivenom): all panels show tissue hyalinization leading to poorly defined cell limits; panels G and I = hemorrhagic foci and glomerular microaneurysms (arrows); panels H and J = medullary sections showing the flattened epithelial lining of tubular segments with a distended lumenal space. A description of the alterations is provided in the text. 

There was no difference in the number of eryth-rocytes 2 h (G2 vs. G1) or 7.2 h (G3 vs. G1) after envenomation (Fig. 4C). The delayed administraron of antivenom (G4) attenuated the slight increase in the number of erythrocytes in G3 to a level similar to that seen with saline and antivenom alone (Fig. 4C). Other reports have also observed no alterations in the number of erythrocytes, the hematocrit, or the hemoglo-bin concentration in dogs (Sousa-e-Silva et al. 2003) and humans (Sano-Martins et al. 2001) envenomed by C. d. terrificus.

Histological analysis

The kidneys regulate the bodys internal com-position through a complex network of neph-rons and collecting ducts that filter, absorb and secrete fluid and electrolytes and promote the elimination of metabolic waste products via the urine (Santoro et al. 2008). Glomerular damage leads to several pathologies (Greka and Mun-del 2012) and circulating snake venom compo-nents can cause morphological abnormalities that result in functional disturbances.

Figure 5 shows representative panels and insets for the different groups that illustrate the main histological alterations seen in the renal parenchyma. Histological analysis of renal sec-tions from the different experimental groups (G2-G5) showed that morphological changes were not evenly distributed throughout the renal parenchyma since there were areas with visible abnormalities juxtaposed to regions normal in appearance. This heterogeneity reflected the differential effects of venom components on the kidney in that all nephrons were not affect-ed simultaneously or in the same manner. Except for G1 (saline control) that showed the typical normal morphology of renal corpuscles, proximal and distal convoluted tubules, the loop of Henle and collecting ducts (Fig. 5A,B), all the other groups exhibited varying degrees of alterations in their structural segments (Fig. 5C-J). The changes included glomerular alterations (indicated by arrows in the panels and insets of Fig. 5). Major and more numerous glomerular alterations were seen in G2 and G3 (see insets); antivenom (G4) partially prevented the glomerular morphological alterations (inset in G4). Of note were the glomerular alterations in G5 (inset in G5) that received antivenom alone. The greatest structural changes in the cortical tubular nephron segments and medullary collecting tubules were seen in G2: the changes included loss or central collapse of the brush border in the proximal tubules, and luminal widening with cellular casts in the proximal and distal tubules and collecting ducts (Fig. 5C,D). Groups G3, G4, and G5 had a general hyaline appearance in the nephron segments located in the renal cortex that obscured visualization of their cellular constituents (Fig. 5E,G,I). The renal medulla showed less damage in enven-omed rats treated with physiological saline so-lution (G3) (Fig. 5F), whereas greater damage was seen in envenomed rats treated with antivenom (G4) and in rats treated with antivenom alone (G5) (Fig. 5H,J) compared to G3 (Fig. 5F); similar renal alterations in response to antive-nom have been described elsewhere (Oliveira et al. 2021), but the reasons remain to be in-vestigated. All the changes observed here are characteristic of renal disease (Cardoso et al. 1993; Haraldsson et al. 2008).

A comparative analysis of the frequency of his-tological alterations in groups G1-G5 yielded the following scores: G2 = a score of 5-6 repre-senting a very high-frequency of alterations; G3 = 2-3, a relatively low-to-moderate frequency of alterations; G4 and G5 = 4 indicating a high frequency, and G1 = 0-1 indicating few or no alterations (most of the alterations were attrib-utable to technical artifacts).

The results of this study allow us to address two specific issues: (a) The early onset of AKI: Pinho et al. (2005) have shown that ap-proximately two-thirds of patients who develop AKI following envenomation by C. d. terrificus do so within 24 h of being bitten and that the mean time between being bitten and receiving antivenom (among patients with and without AKI) was 3 h (range: 1-48 h). Risk factors for the development of AKI included age (greater for children <12 years old), the time until anti-venom administration (the greater the interval, the greater the risk), and CK >2000 IU/mL; a diuresis >90 mL/h was considered a protective factor. The 2 h time frame used to assess AKI and for antivenom administration in the pres-ent study was based on the mean interval until antivenom administration noted by Pinho et al. (2005). (b) The parameters used to assess AKI: Parameters commonly used to analyze AKI in-duced by C. d. terrificus include urinary output (diuresis) and glomerular filtration rate (based on creatinine clearance), fractional excretion of Na+ and K+, serum creatine kinase (CK), serum and urinary creatinine and proteinuria, although not all of these have the same usefulness (sen-sitivity or predictive value); additional ancillary parameters include hemoglobin, hematocrit, and platelet counts. The choice of parameters used here (creatinine, urea, and proteinuria) as markers for AKI was based on previous reports in the literature and also because these can be easily measured in serum and urine, samples of which can be obtained with relative ease in the clinical setting.

Conclusión

The findings of this study show that C. d. terrificus venom (6 mg kg-1, i.p.) induced AKI in rats within 2 h, with an increase in blood and renal urea, creatinine, and GSH concentrations, as well as enhanced blood GPx activity and renal protein concentrations. These parameters, together with histological analysis, could be potentially useful biomarkers for assessing the severity of AKI. Antivenom was effective in at-tenuating the increase in blood urea, in normal-izing the proteinuria, and in inactivating antioxi-dant defense through CAT activity, but did not protect against lipid peroxidation.

Acknowledgments

The authors thank Coordenagao de Aperfeigoamento de Pes-soal de Nivel Superior (CAPES)/Prosuc (Finance code 001), Probic/Uniso, Financiadora de Estudos e Projetos (FINEP, grant no. 01.10.0659.00), and Fundagao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, grant no. 2016/12599-2) for fellowships. This work was supported by FAPESP (grant nos. 2015/01420-9 and 2016/12599-2).

Conflict of interest: The authors have no con-flicts of interest related to this work.

Authors’ contributions: EHY, MMJD, ICFO, and JAMF did the experiments under super-vision by YOF; JCC milked the snakes and provided the venom; DG was responsible for interpreting the oxidative stress data; MACH was responsible for the histological analyses. VMHY and YOF designed the study, and YOF, DG, MACH, and SH wrote the manuscript.

References

Aebi H. 1984. Catalase in vitro. Methods in En-zymology. 105:121-126. [ Links ]

Agency for Toxic Substances and Disease Registry (ATSDR). 2008. Toxicological Profile for Phenol. Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service. [Accessed July 2, 2020]. Available from: https://www.atsdr.cdc.gov/toxfaqs/tfacts115. pdf [ Links ]

Albuquerque PL, Jacinto CN, Silva Junior GB, Lima JB, Veras MS, Daher EF. 2013. Acute kid-ney injury caused by Crotalus and Bothrops snake venom: a review of epidemiology, clinical manifestations and treatment. Revista do Instituto de Medicina Tropical de Sao Paulo. 55(5):295-301. [ Links ]

N, Daher EF. 2020. Clinical assessment and pathophysiology of Bothrops venom-related acute kidney injury: a scoping review. Journal of Venomous Animals and their Toxins Includ-ing Tropical Diseases. 26:e20190076. [ Links ]

Alegre VS, Barone JM, Yamasaki SC, Zambot-ti-Villela L, Silveira PF. 2010. Lipoic acid effects on renal function, aminopeptidase activities and oxidative stress in Crotalus durissus terrifi-cus envenomation in mice. Toxicon. 56(3):402-410. [ Links ]

Al Shoyaib A, Archie SR, Karamyan VT. 2019. Intraperitoneal route of drug administration: should it be used in experimental animal stud-ies? Pharmceutical Research. 37(1):12. [ Links ]

The missing reference Amaral et al. (1997) (cited at the bottom of the left-hand column of page 20 of the main text) into the reference list, placing it before this work by Amora et al. (2008). DN, Martins AMC, Roesner N, Senter R, Ostrowsky T, Weinberg JM, Monteiro HSA. 2008. Mitochondrial dysfunction induced by pancreatic and crotalic (Crotalus durissus terrificus) phospholipases A2 on rabbit proximal tubules suspensions. Toxicon. 52(8):852-857. [ Links ]

Amorim MF, Mello RF. 1954. Intermediate ne-phrosis from snake poisoning in man. American Journal of Pathology. 30(3):479-499. [ Links ]

Azevedo-Marques MM, Cupo P, Coimbra TM, Hering SE, Rossi MA, Laure CJ. 1985. Myone-crosis, myoglobinuria and acute renal failure induced by South American rattlesnake (Crotalus durissus terrificus) envenomation in Brazil. Toxicon. 23(4):631-636. [ Links ]

Azevedo-Marques MM, Hering SE, Cupo P. 1987. Evidence that Crotalus durissus terrificus (South American rattlesnake) envenomation in humans causes myolysis rather than hemoly-sis. Toxicon. 25(11):1163-1168. [ Links ]

Bahrami S, Shahriari A, Tavalla M, Azadma-nesh S, Hamidinejat H. 2016. Blood levels of oxidant/antioxidant parameters in rats infected with Toxoplasma gondii. Oxidative Medicine and Cellular Longevity. 2016:8045969. [ Links ]

Ballatori N, Krance SM, Marchan R, Hammond CL. 2009. Plasma membrane glutathione trans-porters and their roles in cell physiology and pathophysiology. Molecular Aspects of Medicine. 30(1-2):13-28. [ Links ]

Barone JM, Frezzatti R, Silveira PF. 2014. Effects of N-acetyl-L-cysteine on redox status and markers of renal function in mice inoculat-ed with Bothrops jararaca and Crotalus durissus terrificus venoms. Toxicon. 79:1-10. [ Links ]

Barral-Netto M, von Sohsten RL. 1991. Serum kinetics of crotoxin from Crotalus durissus terrificus venom in mice: evidence for a rapid clear-ance. Toxicon. 29(4-5):527-531. [ Links ]

Baudou FG, Litwin S, Lanari LC, Laskowicz RD, Damin CF, Chippaux JP, de Roodt AR. 2017. Antivenom against Crotalus durissus terrificus venom: Immunochemical reactivity and experimental neutralizing capacity. Toxicon. 140:11-17. [ Links ]

Berger M, Vieira MAR, Guimaraes JA. 2012. Acute kidney injury induced by snake and ar-thropod venoms. In: Polenakovic M, editor. Renal failure - The facts. London: InTech Open. p. 157-186. [Accessed April 30, 2022]; Available from:https://www.intechopen.com/books/ renal-failure-the-facts/acute-kidney-injury-in-duced-by-snake-and-arthropod-venoms. [ Links ]

Boer-Lima PA, Gontijo JA, Cruz-Hofling MA. 1999. Histologic and functional renal altera-tions caused by Bothrops moojeni snake venom in rats. American Journal of Tropical Medicine and Hygiene. 61(5):698-706. [ Links ]

Boer-Lima PA, Gontijo JA, Cruz-Hofling MA. 2002. Bothrops moojeni snake venom-induced glomeruli changes in rat. American Journal of Tropical Medicine and Hygiene. 67(2):217-222. [ Links ]

Bucaretchi F, Herrera SRF, Hyslop S, Baracat ECE, Vieira RJ. 2002. Snakebites by Crotalus durissus ssp. in children in Campinas, Sao Paulo, Brazil. Revista do Instituto de Medicina Tropical de Sao Paulo. 44(3):133-138. [ Links ]

Cardoso JLC, Fan HW, Franpa FOS, Jorge MT, Leite RP, Nishioka SA, Avila A, Sano-Martins IS, Tomy SC, Santoro M, et al. 1993. Random-ized comparative trial of three antivenoms in the treatment of envenoming by lance-headed vipers (Bothrops jararaca) in Sao Paulo, Brazil. Quarterly Journal of Medicine. 86(5):315-325. [ Links ]

Cerdá J, Lameire N, Eggers P, Pannu N, Uchino S, Wang H, Bagga A, Levin A. 1988. Epidemiol-ogy of acute kidney injury. Clinical Journal of the American Society of Nephrology. 3(3):881-886. [ Links ]

Chen J, Bhandar B, Kavdia M. 2015. Interaction of ROS and RNS with GSH and GSH/GPX sys-tems. FASEB Journal. 29(Supplement):636.7 (Abstract). [ Links ]

Cruz AH, Mendonga RZ, Petricevich VL. 2005. Crotalus durissus terríficus venom interferes with morphological, functional, and biochemi-cal changes in murine macrophages. Media-tors of Inflammation. 2005(6):349-359. [ Links ]

Cura JE, Blanzaco DP, Brisson CB, Cura MA, Cabrol R, Larrateguy L, Mendez C, Sechi JC, Silveira JS, Theiller E, et al. 2002. Phase I and pharmocokinetic study of crotoxin (cytotoxic PLA^ NSC-624244) in patients with advanced cancer. Clinical Cancer Research. 8:1033-1041. [ Links ]

de Silva HA, Ryan NM, de Silva HJ. 2016. Adverse reactions to snake antivenom, and their prevention and treatment. British Journal of Clinical Pharmacology 81(3):446-452. [ Links ]

Ellman GL. 1959. Tissue sulfhydryl groups. Archives of Biochemistry and Biophysics. 82(1):70-77. [ Links ]

Ferreira ALA, Matsubara LS. 1997. Radicais livres: conceitos, doengas relacionadas, sistema de defesa e estresse oxidativo. Revista da Associagao Médica Brasileira. 43(1):61-68. [ Links ]

Frare BT, Silva Resende YK, Dornelas BC, Jorge MT, Souza Ricarte VA, Alves LM, Izidoro LFM. 2019. Clinical, laboratory, and therapeutic as-pects of Crotalus durissus (South American rat-tlesnake) victims: a literature review. BioMedi-cal Research International. 2019:1345923. [ Links ]

Frezzatti R, Silveira PF. 2011. Allopurinol reduces the lethality associated with acute renal failure induced by Crotalus durissus terríficus snake. PLoS Neglected Tropical Diseases. 5(9):e1312. [ Links ]

Gois PHF, Martines MS, Ferreira D, Volpini R, Canale D, Málaque C, Crajoinas R, Girardi ACC, Shimizu MHM, Seguro AC. 2017. Allopurinol attenuates acute kidney injury follow-ing Bothrops jararaca envenomation. PLoS Neglected Tropical Diseases. 11(11):e0006024. [ Links ]

Gongalves R, Vargas LS, Lara MVS, Güllich A, Mandredini V, Ponce-Soto L, Marangoni S, Dal Belo CA, Mello-Carpes PB. 2014. Intrahip-pocampal infusion of crotamine isolated from Crotalus durissus terríficus alters plasma and brain biochemical parameters. International Journal of Environmental Research and Public Health. 11:11438-11449. [ Links ]

Gowda S, Desai PB, Kulkarni SS, Hull VV, Math AAK, Vernekar SN. 2010. Markers of renal func-tion tests. North American Journal of Medical Science. 2(4):170-173. [ Links ]

Greka A, Mundel P 2012. Cell biology and pa-thology of podocytes. Annual Review of Physi-ology. 74:299-323. [ Links ]

Guarnieri M. 2016. Considering the risks and safety of intraperitoneal injections. Laboratory Animals 45:131. [ Links ]

Gutiérrez JM, Calvete JJ, Habib AG, Harrison RA, Williams DJ, Warrell DA. 2017. Snakebite envenoming. Nature Reviews Disease Primers. 3:17063. [ Links ]

Hadler WA, Vital Brazil O. 1966. Pharmacology of crystalline crotoxin. IV. Nephrotoxicity. Memorias do Instituto Butantan. 33(3):1001-1008. [ Links ]

Halliwell B, Gutteridge JMC. 1999. Antioxidant defense enzymes: the glutathione peroxidase family. In: Halliwell B, Gutteridge JMC (eds.) Free radicals in biology and medicine. 3rd ed. Oxford: Clarendon Press. p. 140-146. [ Links ]

Hampel M, Blasco J, Martín Díaz ML. 2016. Biomarkers and effects. In: Blasco J, Chap-man PM, Campana O, Hampel M (eds.) Marine ecotoxicology. New York: Academic Press. p. 121-165. [ Links ]

Haraldsson B, Nystrom J, Deen WM. 2008. Properties of the glomerular barrier and mech-anisms of proteinuria. Physiological Reviews. 88(2):451-487. [ Links ]

Harris JB, Scott-Davey T. 2013. Secreted phospholipases A of snake venoms: effects on the peripheral neuromuscular system with comments on the role of phospholipases A in disorders of the CNS and their uses in industry. Toxins. 5(12):2533-2571. [ Links ]

Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. 2010. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biology. 8(6):e1000412. [ Links ]

Kini RM. 2003. Excitement ahead: structure, function and mechanism of snake venom phos-pholipase A2 enzymes. Toxicon. 42(8):827-840. [ Links ]

León G, Herrera M, Segura Á, Villalta M, Vargas M, Gutiérrez JM. 2013. Pathogenic mecha-nisms underlying adverse reactions induced by intravenous administration of snake antiven-oms. Toxicon. 76:63-76. [ Links ]

Linardi A, Rocha e Silva TAA, Miyabara EH, Franco-Penteado CF, Cardoso KC, Boer PA, Moriscot AS, Gontijo JAR, Joazeiro PP, Col-lares-Buzato CB, et al. 2011. Histological and functional renal alterations caused by Bothrops altematus snake venom: expression and activ-ity of Na+/K+ ATPase. Biochimica Biophysica Acta - General Subjects. 1810(9):895-906. [ Links ]

Lu SC. 2013. Glutathione synthesis. Biochimica Biophysica Acta. 1830(5):3143-3153. [ Links ]

Lucchi L, Bergamini S, lannone A, Perrone S, Stipo L, Olmeda F, Caruso F, Tomasi A, Al-bertazzi A. 2005. Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments. Artificial Organs. 29(1):67-72. [ Links ]

Martins AMC, Toyama MH, Havt A, Novello JC, Marangoni S, Fonteles MC, Monteiro HS. 2002. Determination of Crotalus durissus cascavella venom components that induce renal toxicity in isolated rat kidneys. Toxicon. 40(8):1165-1171. [ Links ]

Martins AMC, Lima AAM, Toyama MH, Marangoni S, Fonteles MC, Monteiro HSA. 2003. Renal effects of supernatant from macrophages activated by Crotalus durissus cascavella venom: the role of phospholipase A2 and cy-clooxygenase. Pharmacology and Toxicology. 92(1):14-20. [ Links ]

Medeiros JM, Oliveira IS, Ferreira IG, Alexan-dre-Silva GM, Cerni FA, Zottich U, Pucca MB. 2020. Fatal rattlesnake envenomation in north-ernmost Brazilian Amazon: a case report and literature overview. Reports. 3(2):9. [ Links ]

Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A. 2007. Acute kidney injury network. Report of an initiative to improve outcomes in acute kidney injury. Criti-cal Care. 11(2):R31. [ Links ]

Mendonpa-da-Silva I, Tavares AM, Sachett J, Sardinha JF, Zaparolli L, Santos MFG, Lacerda M, Monteiro WM. 2017. Safety and efficacy of a freeze-dried trivalent antivenom for snakebites in the Brazilian Amazon: An open randomized controlled phase IIb clinical trial. PLoS Neglect-ed Tropical Diseases. 11(11):e0006068. [ Links ]

Mohamed F, Endre Z, Jayamanne S, Pianta T, Peake P, Palangasinghe C. 2015. Mecha-nisms underlying early rapid increases in cre-atinine in paraquat poisoning. PLoS One. 10(3):e0122357. [ Links ]

Monteiro HSA, da Silva IMSC, Martins AMC, Fonteles MC. 2001. Actions of Crotalus durissus terrificus venom and crotoxin on the isolated rat kidney. Brazilian Journal of Medical and Biological Research. 34(10):1347-1352. [ Links ]

Morton DB, Jennings M, Buckwell A, Ewbank R, Godfrey C, Holgate B, Inglis I, James R, Page C, Sharman I, et al. 2001. Joint Work-ing Group on Refinement. Refining procedures for the administration of substances. Report of the BVAAWF/FRAME/RSPCA/UFAW Joint Working Group on Refinement. British Veteri-nary Association Animal Welfare Foundation/ Fund for the Replacement of Animals in Medical Experiments/Royal Society for the Preven-tion of Cruelty to Animals/Universities Federa-tion for Animal Welfare. Laboratory Animals. 35(1):1-41. [ Links ]

Mylonas C, Kouretas D. 1999. Lipid peroxida-tion and tissue damage. In Vivo. 13(3):295-309. [ Links ]

National Human Genome Research Institute. 2004. Rat genome compared with human, mouse. The Wellcome Trust. January 4, 2004. [Accessed July 2, 2020]. Available from: http:// genome.wellcome.ac.uk/doc_WTD020720. htm. [ Links ]

National Research Council of the National Academies. 2011. Guide for the Care and Use of Laboratory Animals. 8th ed. Washington DC: National Academies Press. [accessed Septem-ber 14, 2019]. Available from: https://grants. nih.gov/grants/olaw/Guide-for-the-Care-and-use-of-laboratory-animals.pdf [ Links ]

Negrin A, Battocletti MA, Juanena C, Morais V. 2021. Reports of doses administered and adverse reactions to snake antivenom used in Uruguay in 2018. Frontiers in Toxicology. 3:690964 [ Links ]

Nogueira RMB, Sakate M. 2006. Clinical and hematological alterations in dogs during experimental envenomation with Crotalus durissus terríficus venom and treated with antiophidic serum. Journal of Venomous Animals and their Toxins including Tropical Diseases. 12(2):285-296. [ Links ]

Nogueira RMB, Sakate M, Sangiorgio F, Laposy CB, Melero M. 2007. Experimental envenomation with Crotalus durissus terríficus venom in dogs treated with antiophidic serum - part I: clinical evaluation, hematology and myelo-gram. Journal of Venomous Animals and their Toxins including Tropical Diseases. 13(4):800-810. [ Links ]

Ohkawa H, Ohishi N, Yagi K. 1979. Assay for lipid peroxides in animal tissues by thiobar-bituric acid reaction. Analytical Biochemistry. 95(2):351-358. [ Links ]

O’Leary MA, Kornhauser RS, Hodgson WC, Isbister GK. 2009. An examination of the activ-ity of expired and mistreated commercial Aus-tralian antivenoms. Transactions of the Royal Society of Tropical Medicine and Hygiene. 103(9):937-942. [ Links ]

The missing reference to Oliveira et al. (2021) (cited in the first paragraph of page 25 of the proofs) here in the list, before Paglia: Oliveira ICF, Yoshida EH, Dini MMJ, Paschoal ABO, Cogo JC, da Cruz-Hofling MA, Hyslop S, Os-hima-Franco Y. 2021. Evaluation of protection by caffeic acid, chlorogenic acid, quercetin and tannic acid against the in vitro neurotox-icity and in vivo lethality of Crotalus durissus terrificus (South American rattlesnake) venom. Toxins. 13(11):801. DE, Valentine WN. 1967. Study on the quantitative and qualitative char-acterization of erythrocyte glutathione perox-ide. Journal of Laboratory and Clinical Medicine. 70(1):158-169. [ Links ]

Pinho FMO, Zanetta DMT, Burdmann EA. 2005. Acute renal failure after Crotalus durissus snakebite: a prospective survey on 100 pa-tients. Kidney International. 67(2):659-667. [ Links ]

Pinho FMO, Yu L, Burdmann EA. 2008. Snake-bite-induced kidney injury in Latin America. Seminars in Nephrology. 28(4):354-362. [ Links ]

Rodrigues Sgrignolli L, Florido Mendes GE, Carlos CP, Burdmann EA. 2011. Acute kidney injury caused by Bothrops snake venom. Nephron Clinical Practice. 119(2):c131-136; discussion c137. [ Links ]

Rosenfeld G. 1971. Symptomatology, patholo-gy and treatment of snake bites in South America. In: Bücherl W, Buckley EE, Deulofeu V, edi-tors. Venomous animals and their venoms. Vol. 2. New York: Academic Press. p. 345-384. [ Links ]

Sampaio SC, Hyslop S, Fontes MR, Prado-Franceschi J, Zambelli VO, Magro AJ, Brigatte P, Gutierrez VP, Cury Y. 2010. Crotoxin: novel activities for a classic a-neurotoxin. Toxicon. 55(6):1045-1060. [ Links ]

Sánchez EE, Migl C, Suntravat M, Rodriguez-Acosta A, Galan JA, Salazar E. 2019. The neutralizaron efficacy of expired polyvalent antivenoms: An alternative option. Toxicon. 168:32-39. [ Links ]

Sangiorgio F, Sakate M, Nogueira RMB, Tostes RA. 2008. Histopathological evaluation in experimental envenomation of dogs with Crotalus durissus terrificus venom. Journal of Venomous Animals and their Toxins including Tropical Diseases. 14(1):83-87. [ Links ]

Sanhajariya S, Duffull SB, Isbister GK. 2018. Pharmacokinetics of snake venom. Toxins. 10(2):E73. [ Links ]

Sano-Martins IS, Santoro ML, Castro SC, Fan HW, Cardoso JL, Theakston RD. 1997. Plate-let aggregation in patients bitten by the Brazil-ian snake Bothrops jararaca. Thrombosis Research. 87(2):183-195. [ Links ]

Sano-Martins IS, Tomy SC, Campolina D, Dias MB, de Castro SCB, de Sousa-e-Silva MCC, Amaral CFS, Rezende NA, Kamiguti AS, Warrell DA, et al. 2001. Coagulopathy following lethal and non-lethal envenoming of humans by the South American rattlesnake (Crotalus durissus) in Brazil. Quarterly Journal of Medicine. 94(10):551-559. [ Links ]

Santoro ML, Sano-Martins IS, Fan HW, Car-doso JL, Theakston RD, Warrell DA. 2008. Bu-tantan Institute Antivenom Study Group. Hae-matological evaluation of patients bitten by the jararaca, Bothrops jararaca, in Brazil. Toxicon. 51(8):1440-1448. [ Links ]

Santosh MS, Sundaram MS, Sunitha K, Kem-paraju K, Girish KS. 2013. Viper venom-in-duced oxidative stress and activation of inflam-matory cytokines: a therapeutic approach for overlooked issues of snakebite management. Inflammation Research. 62(7):721-731. [ Links ]

Sato N. 2012. Blood urea nitrogen as an inte-grated biomarker for hospitalized heart failure. Circulation Journal. 76(10):2329-2330. [ Links ]

Silva HA, Ryan NM, de Silva HJ. 2015. Adverse reactions to snake antivenom, and their pre-vention and treatment. British Journal of Clini-cal Pharmacology. 81(3):446-452. [ Links ]

Silva JG, Soley BS, Gris V, Pires ARA, Cade-ria SMSC, Eler GJ, Hermoso APM, Bracht A, Dalsenter PR, Acco A. 2011. Effects of the Crotalus durissus terrificus snake venom on hepatic metabolism and oxidative stress. Journal of Biochemistry and Molecular Toxicology. 25(3):195-203. [ Links ]

Silveira PVP, Nishioka SA. 1992. South American rattlesnake bite in a Brazilian teaching hospital. Clinical and epidemiological study of 87 cases with analysis of factors predictive of renal failure. Transactions of the Royal Society of Tropical Medicine and Hygiene. 86(5):562-564. [ Links ]

SINAN - Sistema de Informagao de Agravos de Notificagao [Brazilian Information System for Notifiable Diseases.] 2019. [Accessed Sep-tember 4, 2019]; Available at http://www.por-talsinan.saude.gov.br. [ Links ]

Sitprija V. 2006. Snakebite nephropathy. Ne-phrology (Carlton). 11(5):442-448. [ Links ]

Sitprija V. 2008. Animal toxins and the kidney. Nature Clinical Practice Nephrology. 4(11):616-627. [ Links ]

Sitprija V, Sitprija S. 2016. Animal toxins and renal ion transport: Another dimension in tropical nephrology. Nephrology (Carlton). 21(5):355-362. [ Links ]

Sousa-e-Silva MC, Tomy SC, Ravares FL, Navajas L, Larsson MH, Lucas SR, Kogika MM, Sano-Martins IS. 2003. Hematological, he-mostatic and clinical chemistry disturbances induced by Crotalus durissus terrificus snake venom in dogs. Human and Experimental Toxicology. 22(9):491-500. [ Links ]

Spiteller P, Kern W, Reiner J, Spiteller G. 2001. Aldehydic lipid peroxidation products derived from linoleic acid. Biochimica Biophysica Acta. 1531(3):188-208. [ Links ]

Tabet F, Touyz RM. 2007. Reactive oxygen spe-cies, oxidative stress, and vascular biology in hypertension. In: Lip G, Hall J, editors. Com-prehensive hypertension. St. Louis (MO): Mos-by Elsevier. p. 337-347. [ Links ]

Tan KY, Liew ST, Tan QY, Abdul-Rahman FN, Azmi NI, Sim SM, Tan NH, Khomvilai S, Sitprija V, Tan CH. 2019. Evaluating the physicochemi-cal properties and efficacy of recently expired and aged antivenom products from Thailand and Taiwan. Toxicon. 160:55-58. [ Links ]

Teixeira CF, Landucci EC, Antunes E, Chacur M, Cury Y. 2003. Inflammatory effects of snake venom myotoxic phospholipases A2. Toxicon. 42(8):947-962. 2 [ Links ]

Thongprayoon C, Cheungpasitporn W, Kashani K. 2016. Serum creatinine level, a surrogate of muscle mass, predicts mortality in criti-cally ill patients. Journal of Thoracic Disease. 8(5):E305-E311. [ Links ]

Toyama MH, Costa CR, Belchor MN, Novaes DP, de Oliveira MA, Ie R, Gaeta HH, Toyama DO. 2019. Edema induced by sPLA2 from Crotalus durissus terrificus involves PLC and PKC signaling, activation of cPLA2, and oxidative stress. In: Kumar V, Salgado AA, Athari SS, editors. Inflammation in the 21st Century. Lon-don: IntechOpen. Available from: https://www. intechopen.com/chapters/65249 doi: 10.5772/ intechopen.80848 [ Links ]

Vaidya VS, Ferguson MA, Bonventre JV. 2008. Biomarkers of acute kidney injury. Annual Re-view of Pharmacology and Toxicology. 48:463-493. [ Links ]

Warrell DA. 2004. Snakebites in Central and South America: epidemiology, clinical features, and clinical management. In: Campbell JA, Lamar WW, editors. Venomous reptiles of the Western hemisphere. Vol. 2. Ithaca (NY): Com-stock Publishing Associates/Cornell University Press. p. 709-761. [ Links ]

Weydert CJ, Cullen JJ. 2010. Measurement of superoxide dismutase, catalase, and gluta-thione peroxidase in cultured cells and tissue. Nature Protocols. 5(1):51-66. [ Links ]

Yamasaki SC, Villarroel JS, Barone JM, Zam-botti-Villela L, Silveira PF. 2008. Aminopepti-dase activities, oxidative stress and renal func-tion in Crotalus durissus terrificus envenom-ation in mice. Toxicon. 52(3):445-454. [ Links ]

Yoshida EH, Dini MMJ, Campanholi J, Cogo JC, Grotto D, Hyslop S, Hanai-Yoshida VM, Oshima-Franco Y. 2020. Acute kidney injury caused by the intraperitoneal injection of Bo-throps jararaca venom in rats. Natural Products Research. 34(17):2533-2538. [ Links ]

Zychar BC, Castro NC Jr, Marcelino JR, Gon-palves LR. 2008. Phenol used as a preserva-tive in Bothrops antivenom induces impairment in leukocyte-endothelial interactions. Toxicon. 51(7):1151-1157. [ Links ]

Received: April 01, 2021; Accepted: April 30, 2022

Creative Commons License This is an open-access article distributed under the terms of the Creative Commons Attribution License